Antimicrobial susceptibility pattern of clinical isolates of pseudomonas aeruginosa isolated from patients of lower respiratory tract infections

SpringerPlus

Volumn 1, Issue 1, 2012, Pages 1-4

  Fatima, Anab ^b   Naqvi, Syed Baqir ^a   Khaliq, Sheikh Abdul ^b   Perveen, Shaheen ^c   Jabeen, Sabahat ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b HAMDARD UNIVERSITY   (Pakistan)

^c JINNAH UNIVERSITY FOR WOMEN   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876428734     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-1-70     Document Type: Article

References (27)

1. Agarwal R, Gupta D, Ray P (2006) Epidemiology, risk factors and outcome of nosocomial infections in a respiratory intensive care unit in north India. J Infect 53(2):98-105
2. Akhtar N (2010) Hospital acquired infections in a medical intensive care unit. J Coll Physicians Surg Pak 20(6):386-390
3. Ako-Nai AK, Ikem IC, Akinloye OO, Aboderin AO, Ikem RT, Kassim OO (2006) Characterization of bacterial isolates from diabetic foot infections in Ile-Ife, south western Nigeria. Foot 16(3):158-164
4. Anderson H, Esmail A, Hollowell J, Littlejohns P, Strachen D (1993) Epidemiologically based needs assessment: lower respiratory disease. DHA Project Research Programme, Government publication Publisher: NHS Management Executive, 1993.report 16, pp 6-12
5. Balkhy HH, Cunningham G, Chew FK (2006) Hospital-and community-acquired infections: a point prevalence and risk factors survey in a tertiary care center in Saudi Arabia. Int J Infect Dis 10(4):326-333
6. Bonfiglio G, Carciotto V, Russo G et al (1998) Antibiotic resistance in pseudomonas aeruginosa: an Italian survey. Antimicrob Chemother 41:307-310
7. Bouza E, Garcia-Gorrote F, Cercenado E, Marin M, Diaz MS (1999) Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish pseudomonas aeruginosa study group antimicrob agents chemother, 43rd edn., pp 981-982
8. Bustamante CI, Drusano GI, Wharton RC, Whade GC (1987) Synergism of the combinations of imipenem plus ciprofloxacin and imipenem plus Amikacin against pseudomonas aeruginosa and other bacterial pathogens. Antimicrob Agents Chemother 31(4):632-634
9. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH (1999) Emergence of antibiotic-resistant pseudomonas aeruginosa: comparison of risks associated with different anti pseudomonal agents. Antimicrob Agents Chemother 43:1379-1382
10. Cheesborough M (2002) Medical laboratories manual for trocountries. Tropical Health Technol. Butterworth London 2:479
11. Erasmo AA, Crisostomo AC et al (2004) Randomized comparison of piperacillin/ tazobactam versus imipenem/cilastatin in the treatment of patients with intra-abdominal infections. Asian J Surg 27(3):227-235
12. Friedland IR, Funk E, Khoosal M, Klugman KP (1992) Increased resistance to Amikacin in a neonatal unit following intensive Amikacin usage. Antimicrob Agents Chemother 36(8):1596-1600
13. Gerding DN, Larson TA, Hughes RA et al (1991) Amino glycoside resistance and amino glycoside usage: ten years of experience in one hospital. Antimicrob Agents Chemother 35(7):1284-1290
14. Gilligan PH (1995) Pseudomonas and Burkholderia. In: Murray RR, Baron EJ, Pfaler MA, Tenover FC, Yolken RH (eds) Manual of clinical microbiology. American Society for Microbiology, Washington DC, pp 509-519
15. Hancock REW (1998) Resistance mechanism in pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis 27:289-299
16. Hugbo PG, Olurinola PF (1992) Resistance of pseudomonas aeruginosa to antimicrobial agents: implications in medicine and pharmacy. Nig J Pharm Sci 4:1-10
17. Jarlier V, Fosse T, Philippon A (1996) Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med 22:1057-1065
18. Jarvis WR, Martone WJ (1992) Predominant pathogens in hospital infections. J Antimicrob Chemother 29(A):19-24
19. Lizioli A, Privitera G, Alliata E (2003) Prevalence of nosocomial infections in Italy: result from the Lombardy survey in (2000). J Hosp Infect 54(2):141-148
20. Macfarlane J, Holmes W, Gard P, Macfarlane R, Rose D, Weston V, Leinonen M, Saikku P, Myint S (2001) Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax 56 (2):109-114
21. Mayhall CG (1996) Nosocomial burn wound infection. In: Mayhall GC (ed) Hospital epidemiology and infection control. William and Wilkins Co, Baltimore, MD, USA, pp 225-236
22. National Committee for Clinical Laboratory Standards (1995) Approved standard M2 A7 NCCLS. In: Villanova PA (ed) Performance standards for antimicrobial disk susceptibility tests., p 15, NCCLS T 940 West Valley Road T Suite 1400 T Wayne, PA 19087 T USA, T PHONE 610.688.0100
23. Quinn JP (1998) Clinical problems posed by multiresistant nonfermenting gram-negative pathogens. Clin Infect Dis 27:117-124
24. Rotimi VO, Al-Sweih NA, Feteih J (1998) The prevalence and antibiotic susceptibility pattern of gram-Negative bacterial isolates in two ICUs in Saudi Arabia and Kuwait. Diagn Microbiol Infect Dis 30:53-59
25. Sader HS, Jones RN, Gales AC et al (1998) Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY antimicrobial surveillance program (1997). SENTRY Latin American study group. Diagn Microbiol Infect Dis 32:289-301
26. Samporn S, Chuntima T, Thitiya Y, Chertask D (2004) Prevalence and antimicrobial susceptibility of pseudomonas aeruginosa mucoid and non-mucoid type. SE Asian J Trop Med 35:893-894
27. Trilla A (1994) Epidemiology of nosocomial infections in adult in care units. Intensive Care Med 20(3):1-4, 1